Meeting Highlights Information Registration Visa Letter Application Programme Overview Exhibition Virtual Exhibition Hotels Exhibition Virtual Exhibition Satellite Programme


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Acanthamoeba keratitis in Saudi Arabia: demographics, associated factors, presentation and outcomes: a 34-year case review

Poster Details


First Author: S.Alenezi SAUDI ARABIA

Co Author(s):                     

Abstract Details

Purpose:

Purpose: To report the demographics, frequency of potential predisposing factors, presentation and outcomes of Acanthamoeba keratitis (AK) at a tertiary eye hospital in Riyad, Saudi Arabia over a 34-year period.

Setting:

KING KHALED EYE SPECIALIST HOSPITAL, RIYADH , SAUDI ARABIA

Methods:

Methods|: A retrospective review of all patients diagnosed or referred with AK at the King Khaled Eye Specialist Hospital (KKESH), Riyadh, Saudi Arabia between November 1983 and December 2017 was conducted.

Results:

Results: A total of 52 patients with AK at the tertiary referral hospital in Riyadh, Saudi Arabia, between November 1983 and December 2017, were included. The most commonly documented potential predisposing factors were contact lens wear (84.6%). An initial misdiagnosis of herpetic eye disease was made in 32.5 % of patients. The presenting clinical features based on clinical stage, mild stage (36.5%),the advanced stage (63.5%) Rate of failure was (61.5%) which defined as having a best-corrected visual acuity (BCVA) worse than 20/100 and/or requiring keratoplasty.  Four patients experienced recurrences (7.7%) of AK and one of them developed a scleritis.

Conclusions:

Conclusion AK occurred predominantly in contact lens wearers with typical clinical. The patient demographics, frequency of potential predisposing factors and clinical presentation of AK were similar to case series of different similar studies. The need for clear guideline of treating microbial keratitis will help of early diagnosis of AK and better prognosis.

Financial Disclosure:

None

Back to Poster listing